You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-FLT1 (FLT1) 抗体产品概述

Full name:
anti-Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) 抗体 (FLT1)
在www.antibodies-online.cn可供454 Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) 抗体的36不同的供货商。 再加上,我们可以发FLT1 蛋白 (70)FLT1 试剂盒 (58)和数多这个蛋白质的别的产品。 总共602 FLT1产品已列进来了。
别名:
AI323757, FLT, FLT-1, FLT1, flt1b, sFlt1, VEGFR-1, VEGFR1

所有可销售的anti-FLT1 抗体

您会转到已过滤好的搜索

引用最多的anti-FLT1 抗体

  1. Human Polyclonal FLT1 Primary Antibody for ICC, IF - ABIN151960 : Rahimi, Dayanir, Lashkari: Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. in The Journal of biological chemistry 2000 (PubMed)
    Show all 5 references for ABIN151960

  2. Human Monoclonal FLT1 Primary Antibody for EIA, IF - ABIN115152 : Chi, Hsieh, Hui, Tam: Modified method for double stranded DNA sequencing and synthetic oligonucleotide purification. in Nucleic acids research 1989 (PubMed)
    Show all 3 references for ABIN115152

  3. Human Monoclonal FLT1 Primary Antibody for IHC (fro), IF - ABIN1109475 : Imbert, Rosnet, Marchetto, Ollendorff, Birnbaum, Pébusque: Characterization of a yeast artificial chromosome from human chromosome band 13q12 containing the FLT1 and FLT3 receptor-type tyrosine kinase genes. in Cytogenetics and cell genetics 1994 (PubMed)
    Show all 2 references for ABIN1109475

  4. Human Polyclonal FLT1 Primary Antibody for IHC (p), WB - ABIN115391 : Ahmed, Li, Dunk, Whittle, Rushton, Rollason: Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. in Growth factors (Chur, Switzerland) 1996 (PubMed)
    Show all 2 references for ABIN115391

  5. Human Polyclonal FLT1 Primary Antibody for IHC, ELISA - ABIN1532085 : Shibuya, Yamaguchi, Yamane, Ikeda, Tojo, Matsushime, Sato: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. in Oncogene 1990 (PubMed)

  6. Human Polyclonal FLT1 Primary Antibody for EIA, FACS - ABIN955511 : Wong, Buckman, Clemons, Verma, Dent, Trudeau, Roche, Ebos, Kerbel, Deboer, Sutherland, Emmenegger, Slingerland, Gardner, Pritchard: Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growt in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 (PubMed)

  7. Human Polyclonal FLT1 Primary Antibody for IHC (p) - ABIN373446 : Hohenstein, Colin, Foellmer, Amann, Brekken, Daniel, Hugo: Autocrine VEGF-VEGF-R loop on podocytes during glomerulonephritis in humans. in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010 (PubMed)

更多抗FLT1的相互作用对抗体

Mouse (Murine) Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. These data therefore support a tightly controlled, paracrine signaling mechanism of VEGF-B (显示 VEGFB 抗体) to VEGFR1.

  2. Flt1/VEGF-A (显示 VEGFA 抗体) signalling has stage-specific effects on vascular morphogenesis.

  3. IL-35 treatment reduced collagen-induced arthritis via inhibiting vascular endothelial growth factor and its receptors

  4. the VEGFR-1 tyrosine kinase (显示 TYRO3 抗体) signaling has an effect on angiogenesis.

  5. data suggest that sFlt-1 may have a therapeutic effect on AS, resulting from suppression of VEGF signaling-mediated recruitment of circulating monocytes/macrophages

  6. that Flt-1 plays a critical role in cardiac hypertrophy induced by pressure overload via the activation of AKT (显示 AKT1 抗体)

  7. Flt-1 appears to play a role in oxidative stress, which promotes apoptosis of trophoblasts

  8. This article reviews the current evidence on the clinical utility of the sFlt-1/PlGF (显示 PGF 抗体) ratio at different points in pregnancy and, accordingly, make a proposal for its clinical implementation. [review]

  9. cyclin A1 (显示 CCNA1 抗体) in association with vascular endothelial growth factor receptor 1 (VEGFR1), is required for HSPC (显示 PSMA7 抗体) and their niches to maintain their function and proper interaction

  10. VEGFR1 signaling facilitates angiogenesis in ischemia by recruiting CXCR4 (显示 CXCR4 抗体)+VEGFR1-expressing cells from bone marrow.

Human Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. our data demonstrate an association of higher levels of sFLT-1 with increased expression of miR (显示 MLXIP 抗体)-195-5p in preeclampsia pregnant women.

  2. membranebound VEGFR1 is frequently expressed in normal and cancerous breast epithelium. In addition, reduced or lost VEGFR1 expression may serve as a marker for poor prognosis in patients with breast cancer, who might not optimally benefit from endocrine therapy.

  3. These studies identify uPA (显示 PRAP1 抗体)-dependent de-repression of vegfr1 and vegfr2 (显示 KDR 抗体) gene transcription through binding to HHEX/PRH (显示 HHEX 抗体) as a novel mechanism by which uPA (显示 PRAP1 抗体) mediates the pro-angiogenic effects of VEGF (显示 VEGFA 抗体) and identifies a potential new target for control of pathologic angiogenesis.

  4. This study aimed to analyze the ultrastructure and histomorphometric changes of the human umbilical cord vessels of preeclampsia compared to healthy pregnancies and the possible role of vascular endothelial growth factor (VEGF) and its receptors.

  5. Our results indicate that the genetically coded increased expression of FLT1 by a functional SNP implicates activation in an inflammatory cascade that might eventually lead to CAD (显示 CAD 抗体).

  6. sFlt-1 concentrations in saliva (显示 RAG1AP1 抗体) and gingival crevicular fluid were significantly higher in patients with pre-eclampsia.

  7. Flt-1 blood levels are increased in women who developed early- or late-onset preeclampsia.

  8. CAIX (显示 CA9 抗体) and PTEN (显示 PTEN 抗体) had prognostic importance for metastatic renal cell carcinoma (显示 MOK 抗体) patients receiving first-line VEGFR (显示 KDR 抗体) TKI. Future validation and mechanistic studies are required.

  9. Underexpression of FLT1 is associated with HPV-positive head and neck cancers.

  10. Studies indicate that natural products have shown efficacy and noted to be exert tumor suppressive effects via inhibition of VEGF (显示 VEGFA 抗体) and VEGFR (显示 KDR 抗体) both at mRNA and protein level.

Cow (Bovine) Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. These results suggest that non-dominant follicles maintain a greater concentration of the mRNA expression of both membrane and soluble VEGF receptors; but follicular dominance is related to a reduction in the mRNA expression of sVEGFR1 and sVEGFR2.

  2. VEGFR-1 negatively regulates primary bovine retinal pericytes survival, and its blockade protects the blood-brain barrier integrity.

  3. gamma-Secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1

  4. VEGFR1 mRNA expression was lower at estrus and at the early I and early II luteal stages than at the other stages, whereas VEGFR1 protein expression did not change significantly throughout the estrous cycle (P<0.05)

  5. Alterations in the expression of VEGF-A (显示 VEGFA 抗体) and bFGF (显示 FGF2 抗体) systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.

  6. inhibition of VEGFR-1 results in decrease in number of capillary connections indicating VEGFR-1 ligands promote branching angiogenesis.

  7. TGF-beta1 (显示 TGFB1 抗体) induction of VEGFR-1 in endothelial cells explains pericyte protection of vessels and the selective vulnerability of neonatal vessels to oxygen(VEGFR-1)

  8. the activation of VEGFR-1 and VEGFR-2 (显示 KDR 抗体) heterodimer (VEGFR-1/R-2) is essential for PGI(2 (显示 PTGIR 抗体)) synthesis mediated by VEGF-A (显示 VEGFA 抗体)(165) and VEGF-A (显示 VEGFA 抗体)(121), which cannot be reproduced by the parallel activation of VEGFR-1 and VEGFR-2 (显示 KDR 抗体) homodimers with corresponding agonists

  9. PEDF (显示 SERPINF1 抗体) and VEGFR-1 have roles in the negative regulation of angiogenesis

Pig (Porcine) Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. we analyzed the expression and cellular distribution of Flt-1(VEGFR-1) and Flk-1 (KDR/VEGFR-2 (显示 KDR 抗体))in newborn piglet brain

  2. data shows that members of the VEGF (显示 VEGFA 抗体)-VEGFR (显示 KDR 抗体) system are temporally and spatially well localized for playing key roles during umbilical cord formation and its intensive growth observed after day 75 of pregnancy

  3. The VEGFR1 was stably expressed during the whole lifespan of mesonephric glomeruli, and VEGFR1 is important for the maintenance of endothelial fenestrations.

  4. increased placental expression of the VEGF receptor system is associated with increased placental vascular density observed with the advancement of gestation in the pig.

  5. EGFR (显示 EGFR 抗体), VEGFR (显示 KDR 抗体) and FGFR (显示 FGFR2 抗体) are expressed in porcine oviduct and endometrium during the time of implantation [review]

  6. VEGF ligand-receptor system may play an important role in the development and maintenance of the corpus luteum in pigs.

  7. VEGF (显示 VEGFA 抗体)/Flk-1 (显示 KDR 抗体)/Flt-1 system is activated during myocardial ischemia reperfusion injury.

  8. Hemodialysis graft placement leads to early increases in wall shear stress, VEGF-A (显示 VEGFA 抗体), pro-MMP-9 (显示 MMP9 抗体), MMP-2 (显示 MMP2 抗体), VEGFR-1, VEGFR-2 (显示 KDR 抗体), and TIMP-1 (显示 TIMP1 抗体), which may contribute to the development of venous stenosis.

  9. in experimental intervertebral disc degeneration, VEGF receptors were expressed in the damaged disc and paradiscal tissues

Zebrafish Fms-Related tyrosine Kinase 1 (Vascular Endothelial Growth Factor/vascular Permeability Factor Receptor) (FLT1) interaction partners

  1. Flt1-tyrosine kinase (TK) activity contributed significantly in endothelial cells survival and vascular development during embryo angiogenesis in zebrafish by engaging PI3K/Akt (显示 AKT1 抗体) pathway.

  2. Elevated Notch (显示 NOTCH1 抗体) signaling downstream of perturbed VEGF (显示 VEGFA 抗体) signaling contributes to aberrant flt-1(-/-) blood vessel formation.

  3. Data indicate that the increase in FLT1/sFLT1 protein levels upon miR-10 (显示 LILRB2 抗体) knockdown inhibited the angiogenic behavior of endothelial cells largely by antagonizing vascular endothelial growth factor receptor 2 (显示 KDR 抗体) signaling.

FLT1 抗原简介

Antigen Summary

This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.

Alternative names and synonyms associated with FLT1

  • fms-related tyrosine kinase 1 (FLT1) 抗体
  • vascular endothelial growth factor receptor 1 (CpipJ_CPIJ012087) 抗体
  • FMS-like tyrosine kinase 1 (Flt1) 抗体
  • FMS-related tyrosine kinase 1 (Flt1) 抗体
  • fms-related tyrosine kinase 1 (Flt1) 抗体
  • fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1) 抗体
  • fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (flt1) 抗体
  • vascular endothelial growth factor receptor-1 (FLT-1) 抗体
  • AI323757 抗体
  • FLT 抗体
  • FLT-1 抗体
  • FLT1 抗体
  • flt1b 抗体
  • sFlt1 抗体
  • VEGFR-1 抗体
  • VEGFR1 抗体

Protein level used designations for FLT1

fms-related tyrosine kinase 1 , vascular endothelial growth factor receptor 1 , embryonic receptor kinase 2 , tyrosine-protein kinase receptor FLT , vascular endothelial growth factor receptor-1 , vascular permeability factor receptor , fms-like tyrosine kinase 1 , fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) , tyrosine-protein kinase FRT , FLT-1 , FMS-like tyrosine kinase 1 , Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) , VEGF-receptor , flt-receptor , vascular endothelial growth factor 1 , vascular endothelial growth factor/vascular permeability factor receptor , ascular endothelial growth factor/vascular permeability factor receptor , VEGFR-1 , flt-1 type VEGF receptor , receptor tyrosine kinase Flt1b , soluble fms-like tyrosine kinase 1

GENE ID SPECIES
443088 Ovis aries
6044537 Culex quinquefasciatus
14254 Mus musculus
2321 Homo sapiens
54251 Rattus norvegicus
100732326 Cavia porcellus
503620 Bos taurus
403727 Canis lupus familiaris
374100 Gallus gallus
396763 Sus scrofa
544667 Danio rerio
443182 Ovis aries
anti-FLT1 (FLT1) 抗体 精选生产商
您还需要查找其他产品吗?